Lawsuit accuses CVS of overcharging for generic drugs

July 31, 2015 bySudhin Thanawala

CVS Health Corp. deliberately overcharged some pharmacy customers for generic drugs by submitting claims to their insurance companies at inflated prices, according to a lawsuit filed Thursday in federal court in San Francisco.

The suit says those inflated led to higher co-pays for customers that exceeded what they would have paid for the drugs if they had no insurance and participated in a CVS discount program.

"We've seen people who pay $20 for a 30-day supply as their copayments on a drug that was $11.99 for a 90-day supply had they been in the (discount program)," said Kristen Broz, an attorney with Hausfeld, the firm that filed the suit.

The lawsuit seeks class-action status, a court order prohibiting CVS from engaging in the behavior, and unspecified damages.

Broz estimated that hundreds of thousands of people may have been affected since 2008.

CVS Health spokesman Michael DeAngelis said the Rhode Island-based company had not been served with the lawsuit, so it couldn't comment on it. He said co-pays are determined by a patient's prescription coverage plan and added that a similar suit in Massachusetts was dismissed.

At issue in the lawsuit is CVS's "Health Savings Pass" program, which offers discounts to customers who do not have insurance or choose not to use on hundreds of generic prescription drugs, including generic versions of the antibiotic Penicillin and the antidepressant Prozac, according to the suit.

Instead of presenting with that discounted price, CVS reported the higher price that a normal retail customer not in the Health Savings Pass would pay, the lawsuit alleges.

Customers were then charged co-pays according to those higher prices.

"Not only was the HSP program a means by which CVS could maintain and increase its market share by fending off discounted prices from its competitors, but importantly, CVS also intended that the HSP program would serve as a mechanism to hide CVS's true usual and customary prices from third-party payors," the says.

Explore further: CVS to spend $10.4 B in cash on drug distributor Omnicare

Related Stories

FTC sending refunds over CVS business overcharging

September 4, 2012

(AP)—The Federal Trade Commission says it is mailing refund checks to 13,000 Medicare beneficiaries who were overcharged for drugs because a CVS Caremark Corp. business understated the price of the products.

US pharmacy giant CVS ends tobacco sales

September 3, 2014

CVS, the leading US drug chain by sales, announced Wednesday that it had stopped selling tobacco products and was changing its name to reflect a greater focus on health.

Recommended for you

The powerful meteor that no one saw (except satellites)

March 19, 2019

At precisely 11:48 am on December 18, 2018, a large space rock heading straight for Earth at a speed of 19 miles per second exploded into a vast ball of fire as it entered the atmosphere, 15.9 miles above the Bering Sea.

Revealing the rules behind virus scaffold construction

March 19, 2019

A team of researchers including Northwestern Engineering faculty has expanded the understanding of how virus shells self-assemble, an important step toward developing techniques that use viruses as vehicles to deliver targeted ...

Nanoscale Lamb wave-driven motors in nonliquid environments

March 19, 2019

Light driven movement is challenging in nonliquid environments as micro-sized objects can experience strong dry adhesion to contact surfaces and resist movement. In a recent study, Jinsheng Lu and co-workers at the College ...

Levitating objects with light

March 19, 2019

Researchers at Caltech have designed a way to levitate and propel objects using only light, by creating specific nanoscale patterning on the objects' surfaces.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.